Funder: PhRMA Foundation
Due Dates: October 30, 2026, noon ET (Second-cycle LOI) | November 6, 2026 (First-cycle invited applications) | March 2027 (Second-cycle invited applications; exact deadline provided upon invitation)
Funding Amounts: $30,000 per year in stipend support for 12, 18, or 24 months
Summary: Supports advanced doctoral students translating laboratory discoveries into human applications addressing unmet clinical needs.
Key Information: Only one applicant per lab per cycle may apply in Translational Medicine: either a predoctoral or postdoctoral researcher.
Description
The PhRMA Foundation’s Translational Medicine Predoctoral Fellowship supports U.S. and non-U.S. citizens in advanced doctoral training and thesis research. It funds hypothesis-driven research that moves laboratory discoveries and technological advances toward clinical use, while bringing lessons from the clinic back to the laboratory. The program prioritizes unmet clinical needs and new diagnostic, therapeutic, and computational approaches that improve patient care.
Research areas include human-relevant diagnostics and therapeutics, precision medicine, novel clinical endpoints, alternatives to animal testing, biologically validated modeling and simulation, translational pharmacokinetics and pharmacodynamics, and target or biomarker validation. Proposals must state a therapeutically relevant hypothesis and include human components. Purely descriptive biology and animal-only projects are not responsive.
